N-acetylcysteine inhibits chromium hypersensitivity in coadjuvant chromium-sensitized albino guinea pigs by suppressing the effects of reactive oxygen species

Experimental Dermatology

Volumn 19, Issue 8, 2010, Pages

  Wang, Bour Jr ^a   Guo, Yue Liang ^b   Chang, Ho Yuan ^a   Sheu, Hamm Min ^a   Pan, Min Hsiung ^c   Lee, Yu Hsuan ^a   Wang, Ying Jan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Cement workers; Chromium; Chromium hypersensitivity; N acetylcysteine; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; CEMENT; CHROMIUM; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRUG INHIBITION; FEMALE; HYPERSENSITIVITY; NONHUMAN; SKIN ALLERGY; SKIN BIOPSY; SKIN MANIFESTATION;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CHROMIUM; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE; GUINEA PIGS; HYDROGEN PEROXIDE; MALONDIALDEHYDE; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 77954851324     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.01045.x     Document Type: Article

References (72)

1. Costa M, Klein C B. Toxicity and carcinogenicity of chromium compounds in humans [see comment]. Crit Rev Toxicol 2006, 36:155-163.
2. Burrows D. Adverse chromate reactions on the Skin: Chromium: Metabolism and Toxicity. 2000, 137-163. Burrows D. eds, Boca Raton, CRC Press Inc
3. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Ind Med 1990, 17:189-215.
4. Cohen M D, Kargacin B, Klein C B, Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit Rev Toxicol 1993, 23:255-281.
5. Marks J G, Elsner P, DeLeo V. Contact and Occupational Dermatology 2002, 344-346. Missouri, Mosby Inc.
6. Nielsen N H, Menne T. Allergic contact sensitization in an unselected Danish population. The Glostrup Allergy Study, Denmark [erratum appears in Acta Derm Venereol (Stockh) 1993 Oct: 73(5): 397]. Acta Derm Venereol 1992, 72:456-460.
7. Shelnutt S R, Goad P, Belsito D V. Dermatological toxicity of hexavalent chromium. Crit Rev Toxicol 2007, 37:375-387.
8. Bagchi D, Stohs S J, Downs B W, Bagchi M, Preuss H G. Cytotoxicity and oxidative mechanisms of different forms of chromium [see comment]. Toxicology 2002, 180:5-22.
9. Valko M, Morris H, Cronin M T D. Metals, toxicity and oxidative stress. Curr Med Chem 2005, 12:1161-1208.
10. Bickers D R, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006, 126:2565-2575.
11. Lopez-Torres M, Shindo Y, Packer L. Effect of age on antioxidants and molecular markers of oxidative damage in murine epidermis and dermis. J Invest Dermatol 1994, 102:476-480.
12. Lontz W, Sirsjo A, Liu W, Lindberg M, Rollman O, Torma H. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Free Radic Biol Med 1995, 18:349-355.
13. Niwa Y, Iizawa O. Abnormalities in serum lipids and leukocyte superoxide dismutase and associated cataract formation in patients with atopic dermatitis. Arch Dermatol 1994, 130:1387-1392.
14. Sarnstrand B, Jansson A H, Matuseviciene G, Scheynius A, Pierrou S, Bergstrand H. N,N'-diacetyl-l-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. J Pharmacol Exp Ther 1999, 288:1174-1184.
15. Sharkey P, Eedy D J, Burrows D, McCaigue M D, Bell A L. A possible role for superoxide production in the pathogenesis of contact dermatitis. Acta Derm Venereol 1991, 71:156-159.
16. Fuchs J, Zollner T M, Kaufmann R, Podda M. Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 2001, 30:337-353.
17. Matos T J, Duarte C B, Goncalo M, Lopes M C. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line. Immunol Cell Biol 2005, 83:607-614.
18. Maziere C, Floret S, Santus R, Morliere P, Marcheux V, Maziere J C. Impairment of the EGF signaling pathway by the oxidative stress generated with UVA. Free Radic Biol Med 2003, 34:629-636.
19. Ikeda M, Hirose Y, Miyoshi K, Kodama H. Nuclear factor kappaB (NF-kappaB) activation by hydrogen peroxide in human epidermal keratinocytes and the restorative effect of interleukin-10. J Dermatol Sci 2002, 28:159-170.
20. Schulze-Osthoff K, Los M, Baeuerle P A. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol 1995, 50:735-741.
21. Rattan V, Sultana C, Shen Y, Kalra V K. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am J Physiol 1997, 273:E453-E461.
22. Belenky S N, Robbins R A, Rennard S I, Gossman G L, Nelson K J, Rubinstein I. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 1993, 122:388-394.
23. Faurschou A, Gniadecki R. TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes. Exp Dermatol 2008, 17:992-997.
24. Gaestel M, Kotlyarov A, Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov 2009, 8:480-499.
25. Sen C K, Packer L. Antioxidant and redox regulation of gene transcription [see comment]. FASEB J 1996, 10:709-720.
26. Winyard P G, Blake D R. Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 1997, 38:403-421.
27. Piguet P F, Grau G E, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 1991, 173:673-679.
28. Enk A H, Katz S I. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992, 89:1398-1402.
29. Goebeler M, Meinardus-Hager G, Roth J, Goerdt S, Sorg C. Nickel chloride and cobalt chloride, two common contact sensitizers, directly induce expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule (ELAM-1) by endothelial cells. J Invest Dermatol 1993, 100:759-765.
30. Valko M, Rhodes C J, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
31. Robert L R, Joseph F F. Fisher's Contact Dermatitis 2001, 9-27. Philadelphia, Lippincott Williams and Wilkins
32. Mates J M, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999, 32:595-603.
33. McCall M R, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 1999, 26:1034-1053.
34. Camouse M M, Domingo D S, Swain F R. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol 2009, 18:522-526.
35. Bode A M, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004, 555:33-51.
36. Zafarullah M, Li W Q, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003, 60:6-20.
37. Arfsten D, Johnson E, Thitoff A. Impact of 30-day oral dosing with N-acetyl-l-cysteine on Sprague-Dawley rat physiology. Int J Toxicol 2004, 23:239-247.
38. Avnstorp C. Cement eczema. An epidemiological intervention study. Acta Derm Venereol Suppl (Stockh) 1992, 179:1-22.
39. van Hoogstraten I M, de Groot J, Boden D, von Blomberg B M, Kraal G, Scheper R J. Development of a concomitant nickel and chromium sensitization model in the guinea pig. Int Arch Allergy Immunol 1992, 97:258-266.
40. Polak L. Immunology in Chromium 1983, 51-136. Boca Raton, CRS Press
41. Scheper R J, Noble B, Parker D, Turk J L. The value of an assessment of erythema and increase in thickness of the skin reaction for a full appreciation of the nature of delayed hypersensitivity in the guinea pig. Int Arch Allergy Appl Immunol 1977, 54:58-66.
42. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 1980, 38:161-170.
43. Tian L, Cai Q, Wei H. Alterations of antioxidant enzymes and oxidative damage to macromolecules in different organs of rats during aging. Free Radic Biol Med 1998, 24:1477-1484.
44. Prior R L, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999, 27:1173-1181.
45. Cao G, Alessio H M, Cutler R G. Oxygen-radical absorbance capacity assay for antioxidants [see comment]. Free Radic Biol Med 1993, 14:303-311.
46. Kimber I, Basketter D A, Gerberick G F, Dearman R J. Allergic contact dermatitis. Int Immunopharmacol 2002, 2:201-211.
47. White S I, Friedmann P S, Moss C, Simpson J M. The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol 1986, 115:663-668.
48. Cumberbatch M, Dearman R J, Griffiths C E, Kimber I. Langerhans cell migration. Clin Exp Dermatol 2000, 25:413-418.
49. Cumberbatch M, Dearman R J, Kimber I. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 1997, 92:388-395.
50. Cumberbatch M, Dearman R J, Antonopoulos C, Groves R W, Kimber I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology 2001, 102:323-330.
51. Wang B-J, Shiao J-S, Chen C-J, Lee Y-C, Guo Y-L. Tumour necrotizing factor-alpha promoter and GST-T1 genotype predict skin allergy to chromate in cement workers in Taiwan. Contact Dermatitis 2007, 57:309-315.
52. Klecak G. The Freund's complete adjuvant test and the open epicutaneous test. A complementary test procedure for realistic assessment of allergenic potential. Curr Probl Dermatol 1985, 14:152-171.
53. Magnusson B, Kligman AM. Identification of contact allergens 1970, Springfield IL, Charles C. Thomas Publisher.
54. Male D, Brostoff J, Roth D B, Roitt I. Immunology 2006, 325-340. 7th edn, Philadelphia, PA, Mosby
55. Chase M. Disseminated Graunloma in the Guinea Pig 1959, 673-678. Boston, Little, Brown
56. Pearson C. Development of Arthritis in the Rat Following Injection with Adjuvant 1959, 647-671. Boston, Little, Brown
57. Tastekin N, Aydogdu N, Dokmeci D. Protective effects of l-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res 2007, 56:303-310.
58. Uter W, Ruhl R, Pfahlberg A, Geier J, Schnuch A, Gefeller O. Contact allergy in construction workers: results of a multifactorial analysis. Ann Occup Hyg 2004, 48:21-27.
59. Fregert S, Gruvberger B, Sandahl E. Reduction of chromate in cement by iron sulfate. Contact Dermatitis 1979, 5:39-42.
60. Bradberry S M, Vale J A. Therapeutic review: is ascorbic acid of value in chromium poisoning and chromium dermatitis? J Toxicol Clin Toxicol 1999, 37:195-200.
61. Avnstorp C. Prevalence of cement eczema in Denmark before and since addition of ferrous sulfate to Danish cement. Acta Derm Venereol 1989, 69:151-155.
62. Mizuashi M, Ohtani T, Nakagawa S, Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 2005, 124:579-586.
63. Kelly G S. Clinical applications of N-acetylcysteine. Altern Med Rev 1998, 3:114-127.
64. Rao G N, Katki K A, Madamanchi N R, Wu Y, Birrer M J. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J Biol Chem 1999, 274:6003-6010.
65. Vlahopoulos S, Boldogh I, Casola A, Brasier A R. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 1999, 94:1878-1889.
66. Xia C, Hu J, Ketterer B, Taylor J B. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J 1996, 313(Pt 1):155-161.
67. Hoffer E, Baum Y, Nahir A M. N-acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes. Mediators Inflamm 2002, 11:321-323.
68. Abe S, Takizawa H, Sugawara I, Kudoh S. Diesel exhaust (DE)-induced cytokine expression in human bronchial epithelial cells: a study with a new cell exposure system to freshly generated DE in vitro. Am J Respir Cell Mol Biol 2000, 22:296-303.
69. Barry H, John M C. Gutterridge: Free Radicals In Biology And Medicine 2007, 207-220. 4th edn, New York, Oxford University Press Inc
70. Fishbane S, Durham J H, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004, 15:251-260.
71. AMR Monographs, Volume 1. N-Acetylcysteine 2003, Dover, Thorne Research, Inc.
72. Estimating The Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers 2002, Rockville, U.S. Food and Drug Administration